Sun Pharmaceutical Industries’ Foundation for Disease Elimination and Control of India (FDEC-INDIA), has commenced phase 1 roll-out of Malaria demonstration project at Mandla in Madhya Pradesh. This phase will focus on community awareness and education programs among the community residents in Mandla.

As part of the Phase 1 roll-out, in addition to the community awareness programmes, FDEC will begin intense case & surveillance-based malaria control using RDTs, ACTs, LLIN bednets and insecticide spray. The Foundation for Disease Elimination and Control of India has been established by Sun Pharmaceutical Industries for disease elimination and control initiatives undertaken through its CSR programme.

Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.